首页> 外文OA文献 >HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination

【2h】

HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination

机译：新辅助多西紫杉醇联合表柔比星联合治疗局部晚期乳腺癌中HER-2，p53，p21和激素受体蛋白的表达是反应和预后的预测因素

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Daniel G Tiezzi; Jurandyr M Andrade; Alfredo Ribeiro-Silva; Fábio E Zola; Heitor RC Marana; Marcelo G Tiezzi;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination [J] . Daniel G Tiezzi, Jurandyr M Andrade, Alfredo Ribeiro-Silva, BMC Cancer . 2007,第1期

机译：HER-2，p53，p21和激素受体蛋白表达是新辅助多西紫杉醇联合表柔比星联合治疗局部晚期乳腺癌的反应和预后的预测因素
2. HER-2,P53 and Hormonal Receptors Protein Expression as Predictive Factors in Breast Cancer Prognosis [J] . seyed Mohanmmad Rabiee Hashemi, Somayeh Rabiee Hashemi 癌症生物学与医学（英文版） . 2008,第006期

机译：HER-2，P53和激素受体蛋白表达作为乳腺癌预后的预测因素
3. 5174 Predictive factors of response to neoadjuvant 3-weekly epirubicin (EPI) plus docetaxel (DOC) chemotherapy (CT) in locally advanced breast cancer (LABC): a prospective phase II trial [J] . M.R.Strada, M.Frascaroli, R.Palumbo, European Journal of Cancer Supplements . 2009,第2期

机译：5174在局部晚期乳腺癌（LABC）中对新辅助药物每周3次表柔比星（EPI）联合多西他赛（DOC）化疗（CT）的反应的预测因素：一项前瞻性II期试验
4. Functional Imaging of Neoadjuvant Chemotherapy Response in Women with Locally Advanced Breast Cancer using Diffuse Optical Spectroscopy [C] . Hany Soliman, Martin J. Yaffe, Gregory J. Czarnota Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2009

机译：弥漫光学光谱学局部晚期乳腺癌女性新辅助化疗反应的功能成像
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. HER-2 p53 p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination [O] . Daniel G Tiezzi, Jurandyr M Andrade, Alfredo Ribeiro-Silva, 2007

机译：新辅助多西紫杉醇联合表柔比星联合治疗局部晚期乳腺癌中HER-2p53p21和激素受体蛋白的表达是反应和预后的预测因素
7. HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination [O] . Tiezzi, Daniel G, Andrade, Jurandyr M, Ribeiro-Silva, Alfredo , 2007

机译：新辅助多西紫杉醇联合表柔比星联合治疗局部晚期乳腺癌中HER-2，p53，p21和激素受体蛋白的表达是反应和预后的预测因素
8. P53 Mutation Analysis to Predict Tumor Response in Patients Undergoing Neoadjuvant Treatment for Locally Advanced Breast Cancer [R] . Carey, L. A. , Dorsey, K. C. , Dressler, L. , 2006

机译：p53突变分析预测局部晚期乳腺癌新辅助治疗患者的肿瘤反应

HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination

著录项

引文网络

相似文献

相关主题

期刊订阅